Public health advocacy strategies to influence policy agendas: lessons from a narrative review of success in trade policy

[1]  D. Gleeson,et al.  Proposals to waive intellectual property rights for pandemic response products in the World Health Organization pandemic accord need Australia's support , 2023, The Medical journal of Australia.

[2]  L. Winters,et al.  Protecting noncommunicable disease prevention policy in trade and investment agreements , 2022, Bulletin of the World Health Organization.

[3]  B. Townsend.  Defending access to medicines in regional trade agreements: lessons from the Regional Comprehensive Economic Partnership – a qualitative study of policy actors’ views , 2021, Globalization and Health.

[4]  M. Mckee,et al.  Brexit and trade policy: an analysis of the governance of UK trade policy and what it means for health and social justice , 2021, Globalization and Health.

[5]  D. Stuckler,et al.  Globalization and health policy space: Introducing the WTOhealth dataset of trade challenges to national health regulations at World Trade Organization, 1995-2016. , 2021, Social science & medicine.

[6]  Richard D. Smith,et al.  Corporate power and the international trade regime preventing progressive policy action on non-communicable diseases: a realist review , 2020, Health policy and planning.

[7]  F. Baum,et al.  What Generates Attention to Health in Trade Policy-Making? Lessons From Success in Tobacco Control and Access to Medicines: A Qualitative Study of Australia and the (Comprehensive and Progressive) Trans-Pacific Partnership , 2020, International journal of health policy and management.

[8]  R. Labonté,et al.  Trade Agreements and Public Health: A Primer for Health Policy Makers, Researchers and Advocates , 2020 .

[9]  F. Baum,et al.  Toxic trade: the impact of preferential trade agreements on alcohol imports from Australia in partner countries. , 2019, Addiction.

[10]  R. Labonté,et al.  Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts , 2019, Globalization and Health.

[11]  F. Baum,et al.  How do actors with asymmetrical power assert authority in policy agenda-setting? A study of authority claims by health actors in trade policy. , 2019, Social science & medicine.

[12]  D. Gleeson,et al.  An exposé of the realpolitik of trade negotiations: implications for population nutrition , 2019, Public Health Nutrition.

[13]  A. Thow,et al.  How Neoliberalism Is Shaping the Supply of Unhealthy Commodities and What This Means for NCD Prevention , 2019, International journal of health policy and management.

[14]  R. Labonté,et al.  Trade and nutrition policy coherence: a framing analysis and Australian case study , 2019, Public Health Nutrition.

[15]  Carmen Huckel Schneider,et al.  Global Governance of Front-of-Pack Nutrition Labelling: A Qualitative Analysis , 2019, Nutrients.

[16]  C. B. Olsen.  Human Rights in Global Health: Rights-Based Governance for a Globalizing World , 2019, Nordic Journal of Human Rights.

[17]  Suzanne Zhou.  Managing Fragmentation between International Trade and Investment Law and Global Priorities for Noncommunicable Disease Prevention in Food and Alcohol , 2018, QUT Law Review.

[18]  F. Baum,et al.  How does policy framing enable or constrain inclusion of social determinants of health and health equity on trade policy agendas? , 2018, Critical Public Health.

[19]  B. Townsend,et al.  Power asymmetries, policy incoherence and noncommunicable disease control - a qualitative study of policy actor views , 2018, Critical Public Health.

[20]  R. Labonté,et al.  Trade challenges at the World Trade Organization to national noncommunicable disease prevention policies: A thematic document analysis of trade and health policy space , 2018, PLoS medicine.

[21]  A. Thow,et al.  Analyzing the impacts of global trade and investment on non-communicable diseases and risk factors: a critical review of methodological approaches used in quantitative analyses , 2018, Globalization and Health.

[22]  L. Signal,et al.  International trade and investment law: a new framework for public health and the common good , 2018, BMC Public Health.

[23]  M. Margulis.  Negotiating from the margins: how the UN shapes the rules of the WTO , 2018 .

[24]  P. O’BRIEN,et al.  On the Bottle: Health Information, Alcohol Labelling and the WTO Technical Barriers to Trade Agreement , 2018, QUT Law Review.

[25]  B. Freeman,et al.  Advancing progressive health policy to reduce NCDs amidst international commercial opposition: Tobacco standardised packaging in Australia , 2018, Global public health.

[26]  Shamnad Basheer.  Trumping TRIPS: Indian patent proficiency and the evolution of an evergreening enigma , 2018 .

[27]  F. Baum,et al.  What Enables and Constrains the Inclusion of the Social Determinants of Health Inequities in Government Policy Agendas? A Narrative Review , 2017, International journal of health policy and management.

[28]  H. Jarman.  Trade policy governance: What health policymakers and advocates need to know. , 2017, Health policy.

[29]  Kathleen Ruff.  How Canada Changed from Exporting Asbestos to Banning Asbestos: The Challenges That Had to Be Overcome , 2017, International journal of environmental research and public health.

[30]  A. Thow,et al.  Food supply, nutrition and trade policy: reversal of an import ban on turkey tails , 2017, Bulletin of the World Health Organization.

[31]  Susan Self.  The Quest for Global Governance in Intellectual Property and Public Health: Structural, Discursive, and Institutional Dimensions * , 2017 .

[32]  G. Krikorian.  From AIDS to Free Trade Agreements: Knowledge Activism in Thailand’s Movement for Access to Medicines , 2017 .

[33]  S. Glantz,et al.  Defending strong tobacco packaging and labelling regulations in Uruguay: transnational tobacco control network versus Philip Morris International , 2017, Tobacco Control.

[34]  M. Mckee,et al.  The health impact of trade and investment agreements: a quantitative systematic review and network co-citation analysis , 2017, Globalization and Health.

[35]  Carolyn Deere Birkbeck,et al.  Political origins of health inequities: trade and investment agreements , 2017, The Lancet.

[36]  C. Hawkes,et al.  Nutrition labelling is a trade policy issue: lessons from an analysis of specific trade concerns at the World Trade Organization , 2017, Health promotion international.

[37]  T. Baert.  Trade and Health: A Healthy Relationship? The Place of Trade Policy in the EU's Global Health Agenda , 2016 .

[38]  R. Labonté,et al.  Rhetoric and the law, or the law of rhetoric: How countries oppose novel tobacco control measures at the World Trade Organization. , 2016, Social science & medicine.

[39]  R. Labonté,et al.  The Trans-Pacific Partnership Agreement and health: few gains, some losses, many risks , 2016, Globalization and Health.

[40]  F. Bastos,et al.  Implementing Intellectual Property of Pharmaceuticals in Middle-Income Countries: A Case Study of Patent Regulation in Brazil. , 2016, Journal of health politics, policy and law.

[41]  D. Gleeson,et al.  Is health impact assessment useful in the context of trade negotiations? A case study of the Trans Pacific Partnership Agreement , 2016, BMJ Open.

[42]  D. Gleeson,et al.  Patently obvious: a public health analysis of pharmaceutical industry statements on the Trans-Pacific Partnership international trade agreement , 2016 .

[43]  R. Labonté,et al.  Shaping the discourse: What has the food industry been lobbying for in the Trans Pacific Partnership trade agreement and what are the implications for dietary health? , 2016 .

[44]  Chris Holden,et al.  Tobacco control and the World Trade Organization: mapping member states’ positions after the framework convention on tobacco control , 2015, Tobacco Control.

[45]  R. Labonté,et al.  The role of trade and investment liberalization in the sugar-sweetened carbonated beverages market: a natural experiment contrasting Vietnam and the Philippines , 2015, Globalization and Health.

[46]  A. Kay,et al.  Strengthening Trade and Health Governance Capacities to Address Non-Communicable Diseases in Asia: Challenges and Ways Forward , 2015 .

[47]  S. Jandhyala.  International and domestic dynamics of intellectual property protection , 2015 .

[48]  Richard D. Smith,et al.  Improving regulatory capacity to manage risks associated with trade agreements , 2015, Globalization and Health.

[49]  G. Macnaughton,et al.  Human Rights and Health Impact Assessments of Trade-Related Intellectual Property Rights: A Comparative Study of Experiences in Thailand and Peru , 2015 .

[50]  H. Jarman.  The Politics of Trade and Tobacco Control , 2014 .

[51]  Richard D. Smith,et al.  Capacity building for global health diplomacy: Thailand’s experience of trade and health , 2014, Health policy and planning.

[52]  Stephanie Rosenberg.  Asserting the primacy of health over patent rights: a comparative study of the processes that led to the use of compulsory licensing in Thailand and Brazil. , 2014, Developing world bioethics.

[53]  T. Voon,et al.  Evidentiary Challenges for Public Health Regulation in International Trade and Investment Law , 2014 .

[54]  T. Owen.  THE ‘ACCESS TO MEDICINES’ CAMPAIGN VS. BIG PHARMA , 2014 .

[55]  J. Drope,et al.  Evolving norms at the intersection of health and trade. , 2014, Journal of health politics, policy and law.

[56]  A. Thow,et al.  Development, implementation and outcome of standards to restrict fatty meat in the food supply and prevent NCDs: learning from an innovative trade/food policy in Ghana , 2014, BMC Public Health.

[57]  Andreas Dür,et al.  Public opinion and interest group influence: how citizen groups derailed the Anti-Counterfeiting Trade Agreement , 2013 .

[58]  J. Collin,et al.  ‘Trade policy, not morals or health policy’: The US Trade Representative, tobacco companies and market liberalization in Thailand , 2012, Global social policy.

[59]  L. Forman.  From TRIPS-Plus to Rights-Plus? Exploring Right to Health Impact Assessment of Trade-Related Intellectual Property Rights Through the Thai Experience , 2012 .

[60]  J. Braun.  The Domestic Politics of Negotiating International Trade: Intellectual Property Rights in US-Colombia and US-Peru Free Trade Agreements , 2011 .

[61]  Bernardita Escobar-Andrae.  North-South Agreements on Trade and Intellectual Property beyond TRIPS: An Analysis of US Bilateral Agreements in Comparative Perspective* , 2011 .

[62]  R. Labonté,et al.  Framing international trade and chronic disease , 2011, Globalization and health.

[63]  M. Mackintosh,et al.  Commercial Influence and Global Nongovernmental Public Action in Health and Pharmaceutical Policies , 2011, International journal of health services : planning, administration, evaluation.

[64]  E. Hannah.  NGOs and the European Union: Examining the Power of Epistemes in the EC's TRIPS and Access to Medicines Negotiations , 2011 .

[65]  H. Murphy.  The Making of International Trade Policy: Ngos, Agenda-Setting and the Wto , 2011 .

[66]  Suerie Moon,et al.  Driving a decade of change: HIV/AIDS, patents and access to medicines for all , 2011, Journal of the International AIDS Society.

[67]  B. Swinburn,et al.  Trade and food policy: Case studies from three Pacific Island countries , 2010 .

[68]  J. Morin,et al.  Consensus-seeking, distrust and rhetorical entrapment: The WTO decision on access to medicines , 2010 .

[69]  Katherine E. Smith,et al.  Is the increasing policy use of Impact Assessment in Europe likely to undermine efforts to achieve healthy public policy? , 2010, Journal of Epidemiology & Community Health.

[70]  Judith A. Green,et al.  The WHO Commission on Social Determinants of Health , 2010 .

[71]  M. F. Jorge.  The Peruvian Implementation of the US-Peru FTA: A Model for the World with Room for Improvement , 2010 .

[72]  Maria J Grant,et al.  A typology of reviews: an analysis of 14 review types and associated methodologies. , 2009, Health information and libraries journal.

[73]  A. Thow.  Trade liberalisation and the nutrition transition: mapping the pathways for public health nutritionists , 2009, Public Health Nutrition.

[74]  L. Forman.  'Rights' and Wrongs: What Utility for the Right to Health in Reforming Trade Rules on Medicines? , 2009, Health and human rights.

[75]  S. Gruskin,et al.  Changing global essential medicines norms to improve access to AIDS treatment: Lessons from Brazil , 2009, Global public health.

[76]  N. Drager,et al.  Trade and health: an agenda for action , 2009, The Lancet.

[77]  C. Deere.  The Implementation Game: The TRIPS Agreement and the Global Politics of Intellectual Property Reform in Developing Countries , 2009 .

[78]  Ma,et al.  Trade and Health: Seeking Common Ground , 2008 .

[79]  H. Jarman.  The other Side of the Coin: Knowledge, NGOs and EU Trade Policy , 2008 .

[80]  J. Shiffman,et al.  Generation of political priority for global health initiatives: a framework and case study of maternal mortality , 2007, The Lancet.

[81]  Baogang He,et al.  Global Social Justice at the WTO? The Role of NGOs in Constructing Global Social Contracts , 2007 .

[82]  P. Drahoš.  Four Lessons for Developing Countries from the Trade Negotiations Over Access to Medicines , 2007 .

[83]  C. Blouin.  Trade policy and health: from conflicting interests to policy coherence. , 2007, Bulletin of the World Health Organization.

[84]  Frederick M. Abbott.  The WTO Medicines Decision: World Pharmaceutical Trade and the Protection of Public Health , 2005, American Journal of International Law.

[85]  K. Harvey.  Patents, pills and politics: the Australia-United States Free Trade Agreement and the Pharmaceutical Benefits Scheme. , 2004, Australian health review : a publication of the Australian Hospital Association.

[86]  Susan K. Sell,et al.  Using Ideas Strategically: The Contest Between Business and NGO Networks in Intellectual Property Rights , 2004 .

[87]  M. G. Bloche.  WTO Deference to National Health Policy: Toward an Interpretive Principle , 2002 .

[88]  Frederick M. Abbott.  The Doha Declaration on the TRIPS Agreement and Public Health: Lighting a Dark Corner at the WTO , 2002 .

[89]  P. Hall,et al.  Political Science and the Three New Institutionalisms , 1996 .

[90]  Ahmed Abdel-Latif.  The ACTA and the Plurilateral Enforcement Agenda: Developing Countries and the Contestation of ACTA at the TRIPS Council , 2014 .

[91]  J. Drope,et al.  Tobacco control and trade policy: Proactive strategies for integrating policy norms , 2013, Journal of public health policy.

[92]  Daniel Druckman,et al.  Turning Points in Multilateral Trade Negotiations on Intellectual Property , 2012 .

[93]  N. Drager,et al.  Case I—Analyzing a Complex Multilateral Negotiation: The TRIPS Public Health Declaration , 2012 .

[94]  N. Drager,et al.  Case II—Negotiating Access to HIV/AIDS Medicines: A Study of the Strategies Adopted by Brazil , 2012 .

[95]  David Marsh,et al.  A Skin Not a Sweater: Ontology and Epistemology in Political Science , 2010 .

[96]  E. Blas,et al.  Equity, social determinants and public health programmes. , 2010 .

[97]  Davinia Ovett.  Economic Globalisation and Human Rights: Making Trade Policies More Accountable and Human Rights-Consistent: A NGO Perspective of Using Human Rights Instruments in the Case of Access to Medicines , 2007 .

[98]  John S. Odell.  Negotiating trade : developing countries in the WTO and NAFTA , 2006 .

[99]  John S. Odell,et al.  Negotiating Trade: Reframing the issue: the WTO coalition on intellectual property and public health, 2001 , 2006 .

[100]  D. Daley.  PATENTS AND PILLS , POWER AND PROCEDURE : THE NORTH-SOUTH POLITICS OF PUBLIC HEALTH IN THE WTO , 2003 .

[101]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[102]  M. Haywood.  Debunking 'Conglomo-talk' : a case study of the amicus curiae as an instrument for advocacy, investigation and mobilisation , 2001 .